I'll start: pursuing Exubera despite roughly 10 years of FDA concerns about safety. How many billions were pissed away on this product?
Oh, I left out the decision to have the Arthritis, Pain and Neurology division launch it, instead of the Cardiovascular, Endocrine, and Nephrology division...